# Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting Conditions

> **NCT04407000** · PHASE1 · COMPLETED · sponsor: **World Medicine ILAC SAN. ve TIC. A.S.** · enrollment: 30 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Test: Favipiravir 200 mg (LOQULAR)
- **DRUG:** Reference: Favipiravir 200 mg (Avigan)

## Key facts

- **NCT ID:** NCT04407000
- **Lead sponsor:** World Medicine ILAC SAN. ve TIC. A.S.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-23
- **Primary completion:** 2020-07-20
- **Final completion:** 2020-08-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-08-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04407000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04407000, "Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04407000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*